Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 12-2023 | 09-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 20,573 | 1,013 | 12,121 | 138 | 138 |
| Operating Income | -20,573 | -1,013 | -12,121 | -138 | -138 |
| Other Income | 0 | 3,432 | 0 | 519 | 0 |
| Pre-tax Income | -20,573 | 2,419 | -12,121 | 381 | -138 |
| Income Tax | 576 | N/A | 576 | N/A | 0 |
| Net Income Continuous | -21,149 | 2,419 | -12,697 | 381 | -138 |
| Net Income | $-21,149 | $2,419 | $-12,697 | $381 | $381 |
| EPS Basic Total Ops | -0.31 | 0.27 | -0.19 | 0.12 | N/A |
| EPS Basic Continuous Ops | -0.31 | 1.03 | -0.19 | 0.20 | N/A |
| EPS Diluted Total Ops | -0.31 | 0.27 | -0.19 | 0.12 | N/A |
| EPS Diluted Continuous Ops | -0.31 | 1.03 | -0.19 | 0.20 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.31 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,573 | $-1,013 | $-12,121 | $-138 | $-138 |